DETERMINANTS OF IMMUNOTHERAPY EFFICACY IN ENDOMETRIAL CANCER

NCT07690540 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

510

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Cancer
Immune Checkpoint Inhibitors

Interventions

BIOLOGICAL: Prospective exploratory cohort

Sponsor

European Institute of Oncology

Collaborators

[object Object]